← Leaderboards
Karen Taraszka Hastings
University Of Arizona
$848,385
Attributed
$848,385
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $124.2K · FY2007–24$200K$150K$100K$50K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$848,385 · 2
VA$0 · 1
By mechanism
K08$621,135 · 1
R03$227,250 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Michael S Kuhns$7,740,111
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelAntigensMelanomaMediatingPathway InteractionsImmuneResponseLeadTumorImmunotherapyAntigen ProcessingHistocompatibility Antigens Class IiT-Cell ReceptorT-LymphocyteIn VivoResistanceTumor AntigensHuman DiseaseSulfhydryl CompoundsAntigen PresentationAutoantigensOxidoreductaseDisulfide BondClinically Relevant
Grant awards (13)
MHC class II antigen presentation in melanoma: impact on immune recognition$0
I01 · FY2024 · VA · contact PI
MHC Class II Antigen Presentation In Melanoma: Impact on Immune Recognition$0
I01 · FY2023 · VA · contact PI
MHC class II antigen presentation in melanoma: impact on immune recognition$0
I01 · FY2023 · VA · contact PI
MHC class II antigen presentation in melanoma: impact on immune recognition$0
I01 · FY2022 · VA · contact PI
MHC class II antigen presentation in melanoma: impact on immune recognition$0
I01 · FY2021 · VA · contact PI
GILT and regulation of Treg development in cutaneous autoimmunity$75,750
R03 · FY2015 · AR · contact PI
GILT and regulation of Treg development in cutaneous autoimmunity$75,750
R03 · FY2014 · AR · contact PI
GILT and regulation of Treg development in cutaneous autoimmunity$75,750
R03 · FY2013 · AR · contact PI
MHC Class II Antigen Processing and Immune Recognition of Melanoma$124,227
K08 · FY2011 · AR · contact PI
MHC Class II Antigen Processing and Immune Recognition of Melanoma$124,227
K08 · FY2010 · AR · contact PI
MHC Class II Antigen Processing and Immune Recognition of Melanoma$124,227
K08 · FY2009 · AR · contact PI
MHC Class II Antigen Processing and Immune Recognition of Melanoma$124,227
K08 · FY2008 · AR · contact PI
MHC Class II Antigen Processing and Immune Recognition of Melanoma$124,227
K08 · FY2007 · AR · contact PI